PDB Short entry for 1W12 HEADER HYDROLASE 15-JUN-04 1W12 TITLE UROKINASE TYPE PLASMINOGEN ACTIVATOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: UROKINASE-TYPE PLASMINOGEN ACTIVATOR; COMPND 3 CHAIN: U; COMPND 4 FRAGMENT: RESIDUES 179-425; COMPND 5 SYNONYM: U-PLASMINOGEN ACTIVATOR, UPA; COMPND 6 EC: 3.4.21.73; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS UROKINASE, HYDROLASE, PLASMINOGEN ACTIVATOR EXPDTA X-RAY DIFFRACTION AUTHOR U.JACOB REVDAT 2 24-FEB-09 1W12 1 VERSN REVDAT 1 20-MAY-08 1W12 0 JRNL AUTH E.ZESLAWSKA,U.JACOB,A.SCHWEINITZ,G.COOMBS,W.BODE, JRNL AUTH 2 E.MADISON JRNL TITL CRYSTALS OF UROKINASE TYPE PLASMINOGEN ACTIVATOR JRNL TITL 2 COMPLEXES REVEAL THE BINDING MODE OF JRNL TITL 3 PEPTIDOMIMETIC INHIBITORS. JRNL REF J.MOL.BIOL. V. 328 109 2003 JRNL REFN ISSN 0022-2836 JRNL PMID 12684001 JRNL DOI 10.1016/S0022-2836(03)00267-5 REMARK 2 REMARK 2 RESOLUTION. 2.4 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.4 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 200.0 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.0 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 9709 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREER REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.1994 REMARK 3 FREE R VALUE : 0.2610 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.3 REMARK 3 FREE R VALUE TEST SET COUNT : 513 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1952 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 43 REMARK 3 SOLVENT ATOMS : 104 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.576 REMARK 3 B22 (A**2) : -0.576 REMARK 3 B33 (A**2) : 1.153 REMARK 3 B12 (A**2) : 0.000 REMARK 3 B13 (A**2) : 0.000 REMARK 3 B23 (A**2) : 0.000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006273 REMARK 3 BOND ANGLES (DEGREES) : 1.42529 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.324055 REMARK 3 BSOL : 37.9073 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA.PARAM REMARK 3 PARAMETER FILE 3 : WATER.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : 2995.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : 2995.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1W12 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-JUN-04. REMARK 100 THE PDBE ID CODE IS EBI-20160. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 295 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9763 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.40 REMARK 200 RESOLUTION RANGE LOW (A) : 200.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.5 REMARK 200 R MERGE (I) : 0.14 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA):NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.80450 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 27.50300 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 27.50300 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 37.90225 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 27.50300 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 27.50300 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 113.70675 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 27.50300 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 27.50300 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 37.90225 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 27.50300 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 27.50300 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 113.70675 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 75.80450 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: U REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER U 195 - O2 SL1 U 1245 1.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO U 60C 9.32 -68.83 REMARK 500 ASN U 74 -50.01 -120.59 REMARK 500 ASP U 97 -166.41 -120.33 REMARK 500 ASN U 128 86.43 -157.19 REMARK 500 TYR U 171 -92.63 -117.60 REMARK 500 LYS U 243 -107.58 -79.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "UA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 8-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 9-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 700 THE SHEETS PRESENTED AS "UB" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 7-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 8-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SL1 U1245 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1C5W RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL REMARK 900 MOLECULE, S1-BINDING, SUB- MICROMOLAR REMARK 900 INHIBITOR OF UROKINASE TYPE PLASMINOGEN REMARK 900 ACTIVATOR REMARK 900 RELATED ID: 1C5X RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL REMARK 900 MOLECULE, S1-BINDING, SUB- MICROMOLAR REMARK 900 INHIBITOR OF UROKINASE TYPE PLASMINOGEN REMARK 900 ACTIVATOR REMARK 900 RELATED ID: 1C5Y RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL REMARK 900 MOLECULE, S1-BINDING, SUB- MICROMOLAR REMARK 900 INHIBITOR OF UROKINASE TYPE PLASMINOGEN REMARK 900 ACTIVATOR REMARK 900 RELATED ID: 1C5Z RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL REMARK 900 MOLECULE, S1-BINDING, SUB- MICROMOLAR REMARK 900 INHIBITOR OF UROKINASE TYPE PLASMINOGEN REMARK 900 ACTIVATOR REMARK 900 RELATED ID: 1EJN RELATED DB: PDB REMARK 900 UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN REMARK 900 INHIBITOR COMPLEX REMARK 900 RELATED ID: 1F5K RELATED DB: PDB REMARK 900 UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN- REMARK 900 BENZAMIDINE COMPLEX REMARK 900 RELATED ID: 1F5L RELATED DB: PDB REMARK 900 UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN- REMARK 900 AMILORIDE COMPLEX REMARK 900 RELATED ID: 1F92 RELATED DB: PDB REMARK 900 UROKINASE PLASMINOGEN ACTIVATOR B CHAIN-UKI- REMARK 900 1D COMPLEX REMARK 900 RELATED ID: 1FV9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN MICROUROKINASE IN REMARK 900 COMPLEX WITH 2-AMINO-5-HYDROXY-BENZIMIDAZOLE REMARK 900 RELATED ID: 1GI7 RELATED DB: PDB REMARK 900 A NOVEL SERINE PROTEASE INHIBITION MOTIF REMARK 900 INVOLVING A MULTI-CENTERED SHORT HYDROGEN REMARK 900 BONDING NETWORK AT THE ACTIVE SITE REMARK 900 RELATED ID: 1GI8 RELATED DB: PDB REMARK 900 A NOVEL SERINE PROTEASE INHIBITION MOTIF REMARK 900 INVOLVING A MULTI-CENTERED SHORT HYDROGEN REMARK 900 BONDING NETWORK AT THE ACTIVE SITE REMARK 900 RELATED ID: 1GI9 RELATED DB: PDB REMARK 900 A NOVEL SERINE PROTEASE INHIBITION MOTIF REMARK 900 INVOLVING A MULTI-CENTERED SHORT HYDROGEN REMARK 900 BONDING NETWORK AT THE ACTIVE SITE REMARK 900 RELATED ID: 1GJ7 RELATED DB: PDB REMARK 900 ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR REMARK 900 THE S1 SITES OFSER190 TRYPSIN-LIKE SERINE REMARK 900 PROTEASE DRUG TARGETS REMARK 900 RELATED ID: 1GJ8 RELATED DB: PDB REMARK 900 ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR REMARK 900 THE S1 SITES OFSER190 TRYPSIN-LIKE SERINE REMARK 900 PROTEASE DRUG TARGETS REMARK 900 RELATED ID: 1GJ9 RELATED DB: PDB REMARK 900 ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR REMARK 900 THE S1 SITES OFSER190 TRYPSIN-LIKE SERINE REMARK 900 PROTEASE DRUG TARGETS REMARK 900 RELATED ID: 1GJA RELATED DB: PDB REMARK 900 ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR REMARK 900 THE S1 SITES OFSER190 TRYPSIN-LIKE SERINE REMARK 900 PROTEASE DRUG TARGETS REMARK 900 RELATED ID: 1GJB RELATED DB: PDB REMARK 900 ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR REMARK 900 THE S1 SITES OFSER190 TRYPSIN-LIKE SERINE REMARK 900 PROTEASE DRUG TARGETS REMARK 900 RELATED ID: 1GJC RELATED DB: PDB REMARK 900 ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR REMARK 900 THE S1 SITES OFSER190 TRYPSIN-LIKE SERINE REMARK 900 PROTEASE DRUG TARGETS REMARK 900 RELATED ID: 1GJD RELATED DB: PDB REMARK 900 ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR REMARK 900 THE S1 SITES OFSER190 TRYPSIN-LIKE SERINE REMARK 900 PROTEASE DRUG TARGETS REMARK 900 RELATED ID: 1KDU RELATED DB: PDB REMARK 900 PLASMINOGEN ACTIVATOR (UROKINASE-TYPE, KRINGLE REMARK 900 DOMAIN) (U-PA K) (NMR, MINIMIZED AVERAGE REMARK 900 STRUCTURE) REMARK 900 RELATED ID: 1LMW RELATED DB: PDB REMARK 900 LMW U-PA STRUCTURE COMPLEXED WITH EGRCMK REMARK 900 (GLU-GLY-ARG CHLOROMETHYL KETONE) REMARK 900 RELATED ID: 1O3P RELATED DB: PDB REMARK 900 ELABORATE MANIFOLD OF SHORT HYDROGEN BOND REMARK 900 ARRAYS MEDIATINGBINDING OF ACTIVE SITE- REMARK 900 DIRECTED SERINE PROTEASE INHIBITORS REMARK 900 RELATED ID: 1OWD RELATED DB: PDB REMARK 900 SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF REMARK 900 UROKINASE REMARK 900 RELATED ID: 1OWE RELATED DB: PDB REMARK 900 SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF REMARK 900 UROKINASE REMARK 900 RELATED ID: 1OWH RELATED DB: PDB REMARK 900 SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF REMARK 900 UROKINASE REMARK 900 RELATED ID: 1OWI RELATED DB: PDB REMARK 900 SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF REMARK 900 UROKINASE REMARK 900 RELATED ID: 1OWJ RELATED DB: PDB REMARK 900 SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF REMARK 900 UROKINASE REMARK 900 RELATED ID: 1OWK RELATED DB: PDB REMARK 900 SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF REMARK 900 UROKINASE REMARK 900 RELATED ID: 1SQA RELATED DB: PDB REMARK 900 SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF REMARK 900 UROKINASE REMARK 900 RELATED ID: 1SQO RELATED DB: PDB REMARK 900 SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF REMARK 900 UROKINASE REMARK 900 RELATED ID: 1SQT RELATED DB: PDB REMARK 900 SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF REMARK 900 UROKINASE REMARK 900 RELATED ID: 1URK RELATED DB: PDB REMARK 900 PLASMINOGEN ACTIVATOR (UROKINASE-TYPE) (AMINO REMARK 900 TERMINAL FRAGMENT) (NMR, 15 STRUCTURES) REMARK 900 RELATED ID: 1W0Z RELATED DB: PDB REMARK 900 PLASMINOGEN ACTIVATOR (UROKINASE-TYPE) REMARK 900 RELATED ID: 1W10 RELATED DB: PDB REMARK 900 PLASMINOGEN ACTIVATOR (UROKINASE-TYPE) REMARK 900 RELATED ID: 1W11 RELATED DB: PDB REMARK 900 PLASMINOGEN ACTIVATOR (UROKINASE-TYPE) REMARK 900 RELATED ID: 1W13 RELATED DB: PDB REMARK 900 PLASMINOGEN ACTIVATOR (UROKINASE-TYPE) REMARK 900 RELATED ID: 1W14 RELATED DB: PDB REMARK 900 PLASMINOGEN ACTIVATOR (UROKINASE-TYPE) DBREF 1W12 U 16 244 UNP P00749 UROK_HUMAN 179 425 SEQADV 1W12 SER U 122 UNP P00749 CYS 299 CONFLICT SEQRES 1 U 247 ILE ILE GLY GLY GLU PHE THR THR ILE GLU ASN GLN PRO SEQRES 2 U 247 TRP PHE ALA ALA ILE TYR ARG ARG HIS ARG GLY GLY SER SEQRES 3 U 247 VAL THR TYR VAL CYS GLY GLY SER LEU ILE SER PRO CYS SEQRES 4 U 247 TRP VAL ILE SER ALA THR HIS CYS PHE ILE ASP TYR PRO SEQRES 5 U 247 LYS LYS GLU ASP TYR ILE VAL TYR LEU GLY ARG SER ARG SEQRES 6 U 247 LEU ASN SER ASN THR GLN GLY GLU MET LYS PHE GLU VAL SEQRES 7 U 247 GLU ASN LEU ILE LEU HIS LYS ASP TYR SER ALA ASP THR SEQRES 8 U 247 LEU ALA HIS HIS ASN ASP ILE ALA LEU LEU LYS ILE ARG SEQRES 9 U 247 SER LYS GLU GLY ARG CYS ALA GLN PRO SER ARG THR ILE SEQRES 10 U 247 GLN THR ILE SER LEU PRO SER MET TYR ASN ASP PRO GLN SEQRES 11 U 247 PHE GLY THR SER CYS GLU ILE THR GLY PHE GLY LYS GLU SEQRES 12 U 247 ASN SER THR ASP TYR LEU TYR PRO GLU GLN LEU LYS MET SEQRES 13 U 247 THR VAL VAL LYS LEU ILE SER HIS ARG GLU CYS GLN GLN SEQRES 14 U 247 PRO HIS TYR TYR GLY SER GLU VAL THR THR LYS MET LEU SEQRES 15 U 247 CYS ALA ALA ASP PRO GLN TRP LYS THR ASP SER CYS GLN SEQRES 16 U 247 GLY ASP SER GLY GLY PRO LEU VAL CYS SER LEU GLN GLY SEQRES 17 U 247 ARG MET THR LEU THR GLY ILE VAL SER TRP GLY ARG GLY SEQRES 18 U 247 CYS ALA LEU LYS ASP LYS PRO GLY VAL TYR THR ARG VAL SEQRES 19 U 247 SER HIS PHE LEU PRO TRP ILE ARG SER HIS THR LYS GLU HET SL1 U1245 43 HETNAM SL1 N-((1S)-4-{[AMINO(IMINO)METHYL]AMINO}-1- HETNAM 2 SL1 FORMYLBUTYL)-2-{(3R)-3-[(BENZYLSULFONYL)AMINO]-2- HETNAM 3 SL1 OXO-5-PHENYL-2,3-DIHYDRO-1H-1,4-BENZODIAZEPIN- HETNAM 4 SL1 1-YL}ACETAMIDE FORMUL 2 SL1 C30 H33 N7 O5 S FORMUL 3 HOH *104(H2 O1) HELIX 1 1 ALA U 55 PHE U 59 5 5 HELIX 2 2 LYS U 61 GLU U 62A 5 3 HELIX 3 3 SER U 164 GLN U 170 1 7 HELIX 4 4 PHE U 234 THR U 242 1 9 SHEET 1 UA 9 GLU U 20 PHE U 21 0 SHEET 2 UA 9 LYS U 156 ILE U 163 -1 O MET U 157 N GLU U 20 SHEET 3 UA 9 MET U 180 ALA U 184 -1 O CYS U 182 N ILE U 163 SHEET 4 UA 9 GLY U 226 ARG U 230 -1 O GLY U 226 N ALA U 183 SHEET 5 UA 9 ARG U 206 TRP U 215 -1 O ILE U 212 N THR U 229 SHEET 6 UA 9 PRO U 198 LEU U 203 -1 O LEU U 199 N THR U 210 SHEET 7 UA 9 SER U 135 GLY U 140 -1 O SER U 135 N SER U 202 SHEET 8 UA 9 LYS U 156 ILE U 163 10 O LYS U 156 N GLY U 140 SHEET 9 UA 9 GLU U 20 PHE U 21 -1 O GLU U 20 N MET U 157 SHEET 1 UB 8 PHE U 30 ARG U 36 0 SHEET 2 UB 8 VAL U 38 LEU U 46 -1 O THR U 39 N ARG U 35 SHEET 3 UB 8 TRP U 51 SER U 54 -1 O ILE U 53 N SER U 45 SHEET 4 UB 8 ALA U 104 ARG U 109 -1 O ALA U 104 N SER U 54 SHEET 5 UB 8 MET U 81 LEU U 90 -1 O GLU U 84 N ARG U 109 SHEET 6 UB 8 TYR U 64 LEU U 68 -1 O TYR U 64 N VAL U 85 SHEET 7 UB 8 PHE U 30 ARG U 36 -1 O ALA U 32 N TYR U 67 SHEET 8 UB 8 PHE U 30 ARG U 36 SHEET 1 UC 2 SER U 95 ALA U 96 0 SHEET 2 UC 2 HIS U 99 HIS U 100 -1 O HIS U 100 N SER U 95 SSBOND 1 CYS U 42 CYS U 58 1555 1555 2.03 SSBOND 2 CYS U 50 CYS U 111 1555 1555 2.03 SSBOND 3 CYS U 136 CYS U 201 1555 1555 2.02 SSBOND 4 CYS U 168 CYS U 182 1555 1555 2.03 SSBOND 5 CYS U 191 CYS U 220 1555 1555 2.03 LINK OG SER U 195 C6 SL1 U1245 1555 1555 1.55 SITE 1 AC1 21 HIS U 57 ASP U 97 THR U 97A LEU U 97B SITE 2 AC1 21 ALA U 98 HIS U 99 GLY U 133 SER U 135 SITE 3 AC1 21 ASP U 189 SER U 190 CYS U 191 GLN U 192 SITE 4 AC1 21 SER U 195 SER U 214 TRP U 215 GLY U 216 SITE 5 AC1 21 ARG U 217 GLY U 219 GLY U 226 HOH U2088 SITE 6 AC1 21 HOH U2103 CRYST1 55.006 55.006 151.609 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018180 0.000000 0.000000 0.00000 SCALE2 0.000000 0.018180 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006596 0.00000